As previous study suggested that glycan structures of Igs, haptoglobin, and AGP have great potential to serve as cancer diagnosis, prognosis, and treatment monitoring biomarkers to facilitate personalized medicine21,32, we evaluated glycan structures of Igs and AGP in serum. The gene discussed is CUBN; the disease is cancer.